DUBLIN–(BUSINESS WIRE)–The “India Wealth Management – High Net Worth (HNW) Investors” report has been added to ResearchAndMarkets.com’s offering.
This report analyzes the investing preferences and portfolio allocations of the Indian HNW individuals. It profiles HNW investors in terms of their demographics, analyzes their propensity to invest offshore, and explores the products and services they demand.
India’s HNW investors – which is dominated by professional and earning males – have a relatively high demand for wealth management services, confirming that competition for wealth management business is fierce in the country. To stand out from the crowd, providers should differentiate themselves through their products and services and grow their expertise in specific areas of the wealth management space.
The Indian HNW individuals spread their investments evenly across asset classes, with a slight edge towards equities and cash and near cash products. Although advisory mandates are preferred by the Indian HNW investors the most, the country also stands out in terms of their noteworthy increase in demand for robo-advisory.
Scope
Reasons to Buy
Key Topics Covered:
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/tsyxz3
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…